Search clinical trials for: Paracoracoid SPB

Total 995 results

UCB Pharma

Completed

An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN)

Postherpetic Neuralgia

Germany
Spectrum Pharmaceuticals, Inc

Completed

A Phase I, Open-label, Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Endothelin B Agonist, SPI-1620, in Patients With Recurrent or Progressive Carcinoma

Carcinoma

United States
Otsuka Beijing Research Institute
Otsuka Pharmaceutical Co., Ltd.

Unknown

Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Non-Hodgkin's Lymphoma(NHL) | Multiple Myeloma(MM)

Hong Kong
Association Francaise pour la Recherche Thermale
University Hospital, Grenoble; Floralis

Completed

Evaluation of Spa Therapy in the Treatment of Fibromyalgia (THERMALGI)

Fibromyalgia | Rheumatism, Muscular

France
Shanghai Pharmaceuticals Holding Co., Ltd

Recruiting

Clinical Study of SPH3348 Tablets, a c-Met Inhibitor, in Patients With Advanced Solid Tumors

Solid Tumor

China
Spark Therapeutics

Active, not recruiting

A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)

Lysosomal Storage Diseases | Glycogen Storage Disease Type II | Glycogen Storage Disease Type 2 | Pompe Disease (Late-onset) | Pompe Disease | LOPD | Acid Maltase Deficiency

United States, Canada, Netherlands, France, Denmark, Germany, Italy, United Kingdom
Giresun University
Ankara University; Karadeniz Technical University

Completed

A Cadaveric and Radiologic Study of Sacral Erector Spinae Plane Block (ESPB) (ESPB)

Nerve Block

Turkey
Essity Hygiene and Health AB
Smerud Medical Research Germany Ltd

Completed

Evaluation of Urine Leakage of New Absorbing Incontinence Products in a Home Care Environment

Urinary Incontinence

Germany
Università degli Studi di Ferrara
University Health Network, Toronto; Princess Margaret Hospital, Canada

Unknown

Managing Cancer and Living Meaningfully (CALM) Adapted to Italian Cancer Care Setting (CALM-IT)

Depression | Quality of Life | Anxiety

Italy
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor

Solid Tumor

Korea, Republic of
Merete Haedersdal
Sebacia, Inc.

Completed

Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomography

Acne Vulgaris

Denmark
National University Hospital, Singapore
Otsuka Pharmaceutical Co., Ltd.

Unknown

Phase IIa Dose-Expansion and Biomarker Study of OPB-111077

NPC | Refractory Tumor

Singapore
Korea Otsuka Pharmaceutical Co., Ltd.

Terminated

A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma)

Advanced Hepatocellular Carcinoma

Korea, Republic of
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome

Guillain-Barré Syndrome

Japan
University Hospital, Clermont-Ferrand

Completed

Evaluation of the Effectiveness of a SPA Therapy to "Neyrac-les-Bains" to the Old Subject (60-80 Years Old) With a Chronic Low Back Pain.

Chronic Low Back Pain

France
Otsuka Novel Products GmbH

Terminated

A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer

Breast Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Salivary Gland Cancer | Squamous Cell Carcinoma of the Cervix

United Kingdom
UCB Pharma

Completed

A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy

Diabetic Neuropathy

United States
UCB Pharma

Completed

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Partial Seizures With or Without Secondary Generalization

Germany
UCB Pharma

Completed

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Epilepsy
Otsuka Pharmaceutical Development & Commercialization...

Completed

Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer

Advanced Cancer

United States
Meshalkin Research Institute of Pathology of Circulation

Completed

Normothermia Versus Hypothermia for Valvular Surgery Patients

Valvular Heart Disease

Russian Federation
M.D. Anderson Cancer Center
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

STAT3 Inhibitor for Solid Tumors

Solid Tumor | Advanced Cancer

United States
Supernus Pharmaceuticals, Inc.

Completed

Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems

Conduct Disorder | Attention Deficit Disorder With Hyperactivity

United States
M.D. Anderson Cancer Center
Otsuka Pharmaceutical Co., Ltd.

Terminated

Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes

Leukemia

United States
University of Genova

Unknown

Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot-Marie-Tooth Neuropathy Type 1A (CMT1A) (TreSPE)

Charcot-Marie-Tooth Disease | Charcot-Marie-Tooth Disease Type 1A

Italy
Tanta University

Recruiting

The Efficacy of Ultrasound-Guided Rhomboid Intercostal Block Versus Serratus Plane Block in Mastectomy.

Mastectomy | Rhomboid Intercostal Block | Serratus Plane Block

Egypt
San Diego State University
National Institute of Mental Health (NIMH)

Recruiting

Suicide Prevention for Sexual and Gender Minority Youth (Randomized Controlled Trial)

Suicide

United States
Supernus Pharmaceuticals, Inc.

Recruiting

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

Attention-Deficit/Hyperactivity Disorder

United States
Bayer

Completed

To Evaluate Eye Installation-Tear Free

Sunscreening Agents

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma

Hepatocellular Carcinoma

Japan
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Phase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.

Hepatocellular Carcinoma | Radiotherapy | Narrow Margin

China
MegaPro Biomedical Co. Ltd.

Recruiting

Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors

Solid Tumor, Unspecified, Adult

Taiwan
hanan fawzy

Active, not recruiting

Acute Toxicity After Moderate Hypo-fractionated Intensity Modulated Radiotherapy IMRT or Prostate Cancer

Radiation Toxicity

Egypt
Minia University

Completed

Ultrasound Guided Erector Spinae Plane Block Versus Retrolaminar Plane Block

Analgesia | Post Operative Pain

Egypt
Hospital Clinic of Barcelona

Completed

Sentinel Node After Neoadjuvancy In Node-Positive Breast Cancer (SANA)

Breast Cancer

Spain
SPR Therapeutics, Inc.
NDI Medical, LLC

Completed

Electrical Stimulation for the Treatment of Post-Stroke Shoulder Pain

Shoulder Pain

United States
Bayer

Completed

Sun Protection Factor Assay (338/2016)

Sunscreening Agents

United States
Bayer

Completed

Sun Protection Factor Assay (317/2016) (SPF Assay)

Sunscreening Agents

United States
Bayer

Terminated

Sun Protection Factor Assay (319/2016) (SPF Assay)

Sunscreening Agents

United States
Bayer

Completed

Sun Protection Factor Assay (343/2016)

Sunscreening Agents

United States
Bayer

Completed

Sun Protection Factor Assay (344/2016)

Sunscreening Agents

United States
NYU Langone Health

Completed

Sphenopalatine Ganglion Block to Treat Shoulder Pain During and/or After Cesarean

Ipsilateral Shoulder Pain

United States
Nihon Pharmaceutical Co., Ltd

Completed

Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis

Portal Vein Thrombosis

Japan
Umeå University
Medtronic

Completed

Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass

Cardiopulmonary Bypass | Bleeding Disorder | Platelet Dysfunction Due to Drugs | Platelet Disorder

Sweden
University of Pittsburgh
National Institute of Mental Health (NIMH)

Not yet recruiting

Sleep Promotion Program Primary Care (SPP PC)

Sleep | Sleep Disturbance | Insufficient Sleep

United States
Supernus Pharmaceuticals, Inc.

Terminated

Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment

Attention Deficit Hyperactivity Disorder

United States
Cancer Institute and Hospital, Chinese Academy...

Completed

HA-WBRT-SIB for Brain Metastasis of Lung Cancer

Cognitive Function | Brain Metastases | Lung Neoplasm | Simultaneous Integrated Boost | Hippocampal Avoidance

China
Sahlgrenska University Hospital, Sweden

Completed

Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury (ICAROX2)

Renal Failure | Inflammatory Response | Hemolysis | Cardiopulmonary Bypass | Extracorporeal Circulation; Complications | Circulation Disorder | Renal Plasma Flow, Effective

Sweden
IRCCS San Raffaele Roma
Ettore Sansavini Health Science Foundation

Completed

Effects on Organ Damage and Surgical Outcome of a New Cardiopulmonary Pass System (EVADO) (EVADO)

C.Surgical Procedure; Cardiac

Italy
Supernus Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)

Impulsive Aggression Comorbid With ADHD

United States

Search clinical trials for: Paracoracoid SPB

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations